Showing results (261-270 of 380) with videos related to

Sort By:
Pageof 38
Cancer|September 1, 1993
Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II studyL Bergmann, K Fenchel, E Weidmann, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 24, 1998
Cord blood-IgE as risk factor and predictor for atopic diseasesG Edenharter, R L Bergmann, K E Bergmann, et al.
HNO|February 1, 1987
[Chemotherapy or chemotherapy and radiotherapy in advanced head and neck tumors. A prospective, randomized study comparing the 2 therapeutic modalities]A Klima, C von Ilberg, L Bergmann, et al.
Respiration; International Review of Thoracic Diseases|January 1, 1985
Prognostic value of chest radiograph, serum-angiotensin-converting enzyme and T helper cell count in blood and in bronchoalveolar lavage of patients with pulmonary sarcoidosisM Rust, L Bergmann, T Kühn, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 27, 2026
Phosphatidylethanol as an objective measure of heavy drinking days in a clinical trial for alcohol use disorderMathias E Jensen, Mette K Klausen, Marianne L Bergmann, et al.
Deutsche Medizinische Wochenschrift (1946)|August 1, 1986
[Spontaneous course of LAV/HTLV-III infection. Follow-up of persons from AIDS-risk groups]H R Brodt, E B Helm, A Werner, et al.
Journal of Perinatal Medicine|October 26, 2012
Does docosahexaenoic acid (DHA) status in pregnancy have any impact on postnatal growth? Six-year follow-up of a prospective randomized double-blind monocenter study on low-dose DHA supplementsRenate L Bergmann, Karl E Bergmann, Rolf Richter, et al.
Onkologie|April 1, 1990
Interleukin-2 in combination with interferon-alpha in disseminated malignant melanoma and advanced renal cell carcinoma. A phase I/II studyL Bergmann, E Weidmann, P S Mitrou, et al.
Leukemia|May 1, 1997
Establishment and characterization of a new, factor-independent acute myeloid leukemia line designated Ei501E Weidmann, J Brieger, T Karakas, et al.
Experimental Hematology|January 21, 2000
The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulationG Hübinger, I Scheffrahn, E Müller, et al.
Pageof 38